×

本司产品仅用于科研,不用于临床诊断和治疗

全国免费热线:400-999-2100

您身边的细胞培养专家!

所有分类
  • 所有分类
  • 细胞系
  • 原代细胞
  • 血清
  • 细胞培养基
  • 辅助试剂
  • 细胞凋亡检测试剂盒
  • 细胞房除菌产品
热搜: 胎牛血清 VERO RAW264.7 成纤维细胞 间充质干细胞 上皮细胞

忘记密码

个人邮箱:
验证码: captcha

账号激活

个人邮箱:
×
当前位置:首页 >> 产品中心 >> 细胞资源库 >> 细胞系 >> 

产品中心Cell Resources

联系我们CONTACT US

  • TPC-1 (人甲状腺癌细胞) (STR鉴定正确)
  • TPC-1 (人甲状腺癌细胞) (STR鉴定正确)
  • TPC-1 (人甲状腺癌细胞) (STR鉴定正确)
  • TPC-1 (人甲状腺癌细胞) (STR鉴定正确)
  • TPC-1 (人甲状腺癌细胞) (STR鉴定正确)
  • TPC-1 (人甲状腺癌细胞) (STR鉴定正确)
  • TPC-1 (人甲状腺癌细胞) (STR鉴定正确)

TPC-1 (人甲状腺癌细胞) (STR鉴定正确)

货号:CL-0643

规格:1×10⁶cells/T25培养瓶

价格: ¥1800

生长培养基:DMEM10% FBS1%P/S

数量: - +

  • TPC-1 (人甲状腺癌细胞) (STR鉴定正确)
  • TPC-1 (人甲状腺癌细胞) (STR鉴定正确)
  • TPC-1 (人甲状腺癌细胞) (STR鉴定正确)
  • TPC-1 (人甲状腺癌细胞) (STR鉴定正确)
  • TPC-1 (人甲状腺癌细胞) (STR鉴定正确)
  • TPC-1 (人甲状腺癌细胞) (STR鉴定正确)
  • TPC-1 (人甲状腺癌细胞) (STR鉴定正确)

推荐搭配

套餐1:

TPC-1 (人甲状腺癌细胞) (STR鉴定正确) ¥1800
TPC-1细胞专用培养基
  • ¥350
  • ¥450

现单独购买该产品也可享受限时优惠价!

细胞培养最优解!

套餐组合价:¥2150¥2250

加入购物车

搭配套餐已成功加入购物车!

产品概述
产品信息
名称 TPC-1 (人甲状腺癌细胞) (STR鉴定正确)
别称 TPC1
种属
生长特性 贴壁细胞
细胞形态 上皮细胞样
冻存条件 冻存液:55% 基础培养基+40%FBS+5%DMSO 温度:液氮
培养方案A(默认)
生长培养基:
培养条件:
气相:空气,95%;CO2,5%, 温度:37℃
推荐传代比例 1:3-1:5
推荐换液频率 2-3次/周
参考资料(来源文献)
年龄(性别) 女性;成人
组织来源 甲状腺
细胞类型 肿瘤细胞
肿瘤类型 甲状腺癌细胞
STR鉴定
  • STR位点信息
    Amelogenin X
    CSF1PO 11,12
    D2S1338 16,23
    D3S1358 16,17
    D5S818 8,10
    D7S820 11
    D8S1179 11,17
    D13S317 11,12
    D16S539 9
    D18S51 13,16
    D19S433 13
    D21S11 30,31.2
    FGA 20,21
    PentaD 9,13
    PentaE 18
    TH01 9
    TPOX 11
    vWA 14,18
    D6S1043 18,19
    D12S391 20,26
    D2S441 11
  • STR鉴定图
参考文献
文献列表
  • Ruxolitinib induces apoptosis and pyroptosis of anaplastic thyroid cancer via the transcriptional inhibition of DRP1-mediated mitochondrial fission (2024-02-09)

    作者:Ya-Wen Guo:1.Otolaryngology & Head and Neck Center, Cancer Center, Department of Head and Neck Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, 310014, China. ; 2.Department of Public Health, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310014, China. ; 3.Key Laboratory of Endocrine Gland Diseases of Zhejiang Province, Hangzhou, Zhejiang, 310014, China. ; 4.Clinical Research Center for Cancer of Zhejiang Province, 310014, Hangzhou, Zhejiang, China. ; Lei Zhu:1.Department of Thyroid Surgery, The Fifth Hospital Affiliated to Wenzhou Medical University, Lishui Central Hospital, Lishui City, Zhejiang, 323000, China. ; Yan-Ting Duan:1.Otolaryngology & Head and Neck Center, Cancer Center, Department of Head and Neck Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, 310014, China. ; 2.Key Laboratory of Endocrine Gland Diseases

    期刊:Ruxolitinib induces apoptosis and pyroptosis of anaplastic thyroid cancer via the transcriptional inhibition of DRP1-mediated mitochondrial fission

    DOI:10.1038/s41419-024-06511-1

    影响因子 :9.0

    引用产品: Nthy-ori 3-1 细胞 ,  TPC-1 细胞 ,  B-CPAP [BC-PAP; BCPAP] 细胞 ,  IHH-4 细胞

  • Long non-coding RNA ACTA2-AS1 suppresses metastasis of papillary thyroid cancer via regulation of miR-4428/KLF9 axis (2024-01-09)

    作者:Shuhui Wu:1.Department of Otorhinolaryngology, Shanghai Baoshan Hospital of Integrated Traditional Chinese and Western Medicine, Baoshan Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China. ; Jingjing Zhu:1.Department of Otorhinolaryngology, Shanghai Baoshan Hospital of Integrated Traditional Chinese and Western Medicine, Baoshan Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China. ; Tingting Jiang:1.Department of Otorhinolaryngology, Shanghai Baoshan Hospital of Integrated Traditional Chinese and Western Medicine, Baoshan Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China. ; Ting Cui:1.Department of Thyroid Surgery, Shanghai Baoshan Hospital of Integrated Traditional Chinese and Western Medicine, Baoshan Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, People's Rep

    期刊:Long non-coding RNA ACTA2-AS1 suppresses metastasis of papillary thyroid cancer via regulation of miR-4428/KLF9 axis

    DOI:10.1186/s13148-023-01622-6

    影响因子 :5.7

    引用产品: B-CPAP [BC-PAP; BCPAP] 细胞 ,  TPC-1 细胞 ,  Nthy-ori 3-1 细胞

  • AEBP1 promotes papillary thyroid cancer progression by activating BMP4 signaling (2024-01-18)

    作者:Gaoda Ju:1.Department of Medical Oncology, Key Laboratory of Carcinogenesis & Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing 100142, China; Department of Nuclear Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College (PUMC) Hospital, Chinese Academy of Medical Sciences & PUMC, Beijing 100730, China; Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Beijing 100730, China. ; Tao Xing:1.Department of Medical Oncology, Key Laboratory of Carcinogenesis & Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing 100142, China. ; Miaomiao Xu:1.Shanghai Clinical Research and Trial Center, Shanghai 201210, China. ; Xin Zhang:1.Department of Nuclear Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College (PUMC) Hospital, Chinese Academy of Medical Science

    期刊:AEBP1 promotes papillary thyroid cancer progression by activating BMP4 signaling

    DOI:10.1016/j.neo.2024.100972

    影响因子 :4.8

    引用产品: TPC-1 细胞 ,  B-CPAP [BC-PAP; BCPAP] 细胞

  • RBX1 regulates PKM alternative splicing to facilitate anaplastic thyroid carcinoma metastasis and aerobic glycolysis by destroying the SMAR1/HDAC6 complex (2023-02-21)

    作者:Debin Xu:1.Department of Thyroid Surgery, Second Affiliated Hospital of Nanchang University, No. 1 Minde Road, Nanchang, 330008, China. ; Jichun Yu:1.Department of Thyroid Surgery, Second Affiliated Hospital of Nanchang University, No. 1 Minde Road, Nanchang, 330008, China. ; Yuting Yang:1.Department of Intensive Care Unit, First Affiliated Hospital of Nanchang University, No. 17, Yongwai Main Street, Nanchang, 330006, China. ; Yunyan Du:1.School of Pharmacy, Nanchang University, No. 471, Bayi Road, Nanchang, 330006, China. ; Hongcheng Lu:1.Department of General Surgery, Second Affiliated Hospital of Nanchang University, No. 1 Minde Road, Nanchang, 330008, China. ; Shouhua Zhang:1.Department of General Surgery, Affiliated Children's Hospital of Nanchang University, No. 122, Yangming Road, Nanchang, 330006, China. ; Qian Feng:1.Department of General Surgery, Second Affiliated Hospital of Nanchang University, No. 1 Minde Road, Nanchang, 330008, China. ; Yi Yu:1.Department of Urolo

    期刊:RBX1 regulates PKM alternative splicing to facilitate anaplastic thyroid carcinoma metastasis and aerobic glycolysis by destroying the SMAR1/HDAC6 complex

    DOI:10.1186/s13578-023-00987-8

    影响因子 :7.5

    引用产品: TPC-1 细胞 ,  B-CPAP [BC-PAP; BCPAP] 细胞 ,  KTC-1 细胞 ,  C643 细胞 ,  CAL-62 细胞 ,  8305C 细胞 ,  KMH-2 细胞 ,  KHM-5M 细胞 ,  BHT101 细胞

  • Contribution of microRNA-30d to the prevention of the thyroid cancer occurrence and progression: mechanism and implications (2023-01-25)

    作者:Yanqi Li:1.Department of General Surgery, The Second Affiliated Hospital of Soochow University, 215000, Suzhou, Jiangsu Province, P.R. China. ; Yuan He:1.Department of General Surgery, Heping Hospital Affiliated to Changzhi Medical College, 046000, Changzhi, P.R. China. ; Yuan Chen:1.Department of General Surgery, Tumor Hospital Affiliated to Nantong University, 226361, Nantong, P.R. China. ; Zhaocai He:1.Department of General Surgery, Heping Hospital Affiliated to Changzhi Medical College, 046000, Changzhi, P.R. China. ; Fan Yang:1.Department of General Surgery, Heping Hospital Affiliated to Changzhi Medical College, 046000, Changzhi, P.R. China. ; Chungen Xing:1.Department of General Surgery, The Second Affiliated Hospital of Soochow University, 215000, Suzhou, Jiangsu Province, P.R. China. 15003451953@139.com. ;

    期刊:Contribution of microRNA-30d to the prevention of the thyroid cancer occurrence and progression: mechanism and implications

    DOI:10.1007/s10495-023-01809-5

    影响因子 :7.2

    引用产品: TPC-1 细胞

  • Pleckstrin homology and RhoGEF domain containing G4 (PLEKHG4) leads to the activation of RhoGTPases promoting the malignant phenotypes of thyroid cancer (2023-06-19)

    作者:Qingling Yuan:1.Department of Thyroid Surgery, The First Affiliated Hospital of Zhengzhou University, 1# Jianshe East Road, Zhengzhou, Henan, China. yuanqingling113@163.com. ; Yuxia Fan:1.Department of Thyroid Surgery, The First Affiliated Hospital of Zhengzhou University, 1# Jianshe East Road, Zhengzhou, Henan, China. ; Zheng Liu:1.Department of Thyroid Surgery, The First Affiliated Hospital of Zhengzhou University, 1# Jianshe East Road, Zhengzhou, Henan, China. ; Xiaoming Wang:1.Department of Thyroid Surgery, The First Affiliated Hospital of Zhengzhou University, 1# Jianshe East Road, Zhengzhou, Henan, China. ; Meng Jia:1.Department of Thyroid Surgery, The First Affiliated Hospital of Zhengzhou University, 1# Jianshe East Road, Zhengzhou, Henan, China. ; Yongqiang Dong:1.Department of Thyroid Surgery, The First Affiliated Hospital of Zhengzhou University, 1# Jianshe East Road, Zhengzhou, Henan, China. ; Zushi Geng:1.Department of Thyroid Surgery, The First Affiliated Hospital o

    期刊:Pleckstrin homology and RhoGEF domain containing G4 (PLEKHG4) leads to the activation of RhoGTPases promoting the malignant phenotypes of thyroid cancer

    DOI:10.1007/s10495-023-01861-1

    影响因子 :7.2

    引用产品: TPC-1 细胞 ,  8305C 细胞 ,  BHT101 细胞 ,  CAL-62 细胞 ,  HTh-7 细胞

  • Circ_0124055 promotes the progression of thyroid cancer cells through the miR-486-3p/MTA1 axis (2023-01-05)

    作者:Z Chen:1.Department of Nuclear Medicine, Jiangxi Tumor Hospital, Nanchang, Jiangxi, China. ; Y Su:1.Department of Nuclear Medicine, Jiangxi Tumor Hospital, Nanchang, Jiangxi, China. ; D Peng:1.Department of Nuclear Medicine, Jiangxi Tumor Hospital, Nanchang, Jiangxi, China. ; W Wang:1.Department of Nuclear Medicine, Jiangxi Tumor Hospital, Nanchang, Jiangxi, China. ; J Zhong:1.Department of Nuclear Medicine, Jiangxi Tumor Hospital, Nanchang, Jiangxi, China. ; A Zhou:1.Department of Nuclear Medicine, Jiangxi Tumor Hospital, Nanchang, Jiangxi, China. ; L Tan:1.Department of Nuclear Medicine, The Second Affiliated Hospital of Nanchang University, No.1 Minde Road, Nanchang, 330006, Jiangxi, China. tll_654321@163.com. ;

    期刊:Circ_0124055 promotes the progression of thyroid cancer cells through the miR-486-3p/MTA1 axis

    DOI:10.1007/s40618-022-01998-x

    影响因子 :5.4

    引用产品: TPC-1 细胞 ,  FTC-133 细胞 ,  SW579 [SW 579; SW-579] 细胞 ,  293T [HEK-293T] 细胞

  • LINC02454 promotes thyroid carcinoma progression via upregulating HMGA2 through CREB1 (2023-11-23)

    作者:Yan Cao:1.Department of Nuclear Medicine, The Third Xiangya Hospital, Central South University, Changsha, China. ; Jian Li:1.Department of Nuclear Medicine, The Third Xiangya Hospital, Central South University, Changsha, China. ; Yongliang Du:1.Department of Nuclear Medicine, The Third Xiangya Hospital, Central South University, Changsha, China. ; Yuxuan Sun:1.Department of clinical medicine, Hunan University of Chinese Medicine, Changsha, China. ; Le Liu:1.Department of Nuclear Medicine, The Third Xiangya Hospital, Central South University, Changsha, China. ; Hao Fang:1.Department of Nuclear Medicine, The Third Xiangya Hospital, Central South University, Changsha, China. ; Yan Liang:1.Department of Nuclear Medicine, The Third Xiangya Hospital, Central South University, Changsha, China. ; Shanshan Mao:1.Department of Tumor Chemotherapy, Haikou People's Hospital, Haikou, China. ;

    期刊:LINC02454 promotes thyroid carcinoma progression via upregulating HMGA2 through CREB1

    DOI:10.1096/fj.202301070RR

    影响因子 :4.8

    引用产品: TPC-1 细胞

  • MEX3A induces the development of thyroid cancer via targeting CREB1 (2023-08-02)

    作者:Guoxun Feng:1.Department of General Surgery, Beijing Tiantan Hospital, Beijing, China. ; Penghui Wang:1.Department of General Surgery, Beijing Tiantan Hospital, Beijing, China. ; Hongyi Zhang:1.Department of General Surgery, Beijing Tiantan Hospital, Beijing, China. ; Shi Cheng:1.Department of General Surgery, Beijing Tiantan Hospital, Beijing, China. ; Ying Xing:1.Department of General Surgery, Beijing Tiantan Hospital, Beijing, China. ; Yuan Wang:1.Department of General Surgery, Peking University People Hospital, Beijing, China. ;

    期刊:MEX3A induces the development of thyroid cancer via targeting CREB1

    DOI:10.1002/cbin.12076

    影响因子 :3.9

    引用产品: TPC-1 细胞

  • Receptor Type Protein Tyrosine Phosphatase Epsilon (PTPRE) Plays an Oncogenic Role in Thyroid Carcinoma by Activating the AKT and ERK1/2 Signaling Pathway (2023-07-01)

    作者:Chen Peng:1.Otolaryngology Head and Neck Surgery Research Institute, Shanxi Medical University, Taiyuan, 030001, China. ; 2.Department of Head and Neck Surgery, Shanxi Province Cancer Hospital, Taiyuan, 030001, China. ; 3.Department of Head and Neck Surgery, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Taiyuan, 030001, China. ; 4.Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, 030001, China. ; Chunming Zhang:1.Otolaryngology Head and Neck Surgery Research Institute, Shanxi Medical University, Taiyuan, 030001, China. ; 2.Department of Otolaryngology Head and Neck Surgery, First Hospital of Shanxi Medical University, Taiyuan, 030001, China. ; 3.Shanxi Key Laboratory of Otorhinolaryngology Head and Neck Cancer, First Hospital of Shanxi Medical University, Taiyuan, 030001, China. ; Wenjie Yu:1.Otolaryngology Head and Neck Surgery Research Institute, Shanxi Medical University, Taiyuan, 030001, China. ; 2.Department of Otolaryngology

    期刊:Receptor Type Protein Tyrosine Phosphatase Epsilon (PTPRE) Plays an Oncogenic Role in Thyroid Carcinoma by Activating the AKT and ERK1/2 Signaling Pathway

    DOI:10.2174/1568009623666230118111745

    影响因子 :3.0

    引用产品: TPC-1 细胞 ,  8305C 细胞 ,  CAL-62 细胞 ,  BHT101 细胞

  • Ononin Relieves the Thyroid Cancer Progression through Targeting the Caspase 3 and CD274 Expression Levels (2023-08-01)

    作者:Liangliang Du:1.Department of Endocrinology, Yueyang Hospital of Traditional Chinese Medicine. ; Douyun Zeng:1.Department of Endocrinology, Yueyang Hospital of Traditional Chinese Medicine. ; Xian Hu:1.Department of Endocrinology, Yueyang Hospital of Traditional Chinese Medicine. ; Xi Ren:1.Department of Endocrinology, Yueyang Hospital of Traditional Chinese Medicine. ; Dazhi He:1.Department of Endocrinology, Yueyang Hospital of Traditional Chinese Medicine. ;

    期刊:Ononin Relieves the Thyroid Cancer Progression through Targeting the Caspase 3 and CD274 Expression Levels

    DOI:10.1248/bpb.b22-00796

    影响因子 :2.0

    引用产品: TPC-1 细胞 ,  C643 细胞 ,  Nthy-ori 3-1 细胞 ,  T Cell

  • Ultrasound-targeted microbubble destruction-mediated miR-144-5p overexpression enhances the anti-tumor effect of paclitaxel on thyroid carcinoma by targeting STON2 (2002-02-20)

    作者:Xuefeng Chen:1.Ultrasound Laboratory, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an City, China. ; 2.Ultrasound Department Yancheng No. 1 People's Hospital, Yancheng City, China. ; Xinyuan Zhang:1.Ultrasound Department Yancheng No. 1 People's Hospital, Yancheng City, China. ; Yangyang Qian:1.General Surgery Department, Yancheng No. 1 People's Hospital, Yancheng City, China. ; Enhui Xia:1.Ultrasound Department Yancheng No. 1 People's Hospital, Yancheng City, China. ; Yu Wang:1.Emergency Department, Yancheng No. 1 People's Hospital, Yancheng City, China. ; Qi Zhou:1.Ultrasound Laboratory, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an City, China. ;

    期刊:Ultrasound-targeted microbubble destruction-mediated miR-144-5p overexpression enhances the anti-tumor effect of paclitaxel on thyroid carcinoma by targeting STON2

    DOI:10.1080/15384101.2022.2040778

    影响因子 :5.2

    引用产品: TPC-1 细胞 ,  FTC-133 细胞

  • Long non-coding RNA DUXAP8 promotes the cell proliferation, migration, and invasion of papillary thyroid carcinoma via miR-223-3p mediated regulation of CXCR4 (2002-01-20)

    作者:Yan Liu:1.Department of Ultrasound, China-Japan Union Hospital of Jilin University , Changchun, People's Republic of China. ; Hejia Zhang:1.Department of Ultrasound, China-Japan Union Hospital of Jilin University , Changchun, People's Republic of China. ; Hui Wang:1.Department of Ultrasound, China-Japan Union Hospital of Jilin University , Changchun, People's Republic of China. ; Jiarui Du:1.Department of Ultrasound, China-Japan Union Hospital of Jilin University , Changchun, People's Republic of China. ; Peng Dong:1.Department of Ultrasound, China-Japan Union Hospital of Jilin University , Changchun, People's Republic of China. ; Meihan Liu:1.Department of Ultrasound, China-Japan Union Hospital of Jilin University , Changchun, People's Republic of China. ; Yuanqiang Lin:1.Department of Ultrasound, China-Japan Union Hospital of Jilin University , Changchun, People's Republic of China. ;

    期刊:Long non-coding RNA DUXAP8 promotes the cell proliferation, migration, and invasion of papillary thyroid carcinoma via miR-223-3p mediated regulation of CXCR4

    DOI:10.1080/21655979.2021.1882134

    影响因子 :4.9

    引用产品: TPC-1 细胞

  • Exosomal circular RNA hsa_circ_007293 promotes proliferation, migration, invasion, and epithelial–mesenchymal transition of papillary thyroid carcinoma cells through regulation of the microRNA-653-5p/paired box 6 axis (2012-01-20)

    作者:Qiuyu Lin:1.Nuclear Medicine Department, The First Hospital of Jilin University, Changchun, China. ; Qianle Qi:1.Nuclear Medicine Department, The First Hospital of Jilin University, Changchun, China. ; Sen Hou:1.Nuclear Medicine Department, The First Hospital of Jilin University, Changchun, China. ; Zhen Chen:1.Chengdu Xinke Pharmaceutical Co., LTD, Chengdu, China. ; Nan Jiang:1.Nuclear Medicine Department, The First Hospital of Jilin University, Changchun, China. ; Laney Zhang:1.College of Biological Sciences, Cornell University, Ithaca, NY, USA. ; Chenghe Lin:1.Nuclear Medicine Department, The First Hospital of Jilin University, Changchun, China. ;

    期刊:Exosomal circular RNA hsa_circ_007293 promotes proliferation, migration, invasion, and epithelial–mesenchymal transition of papillary thyroid carcinoma cells through regulation of the microRNA-653-5p/paired box 6 axis

    DOI:10.1080/21655979.2021.2000745

    影响因子 :4.9

    引用产品: TPC-1 细胞

  • TEAD4 overexpression suppresses thyroid cancer progression and metastasis in vitro by modulating Wnt signaling (2012-01-20)

    作者:Buyong Zhang: 1.Department of Thyroid and Breast, Cangzhou Central Hospital, Cangzhou, China; Qingfeng Shi: 1.Department of Thyroid and Breast, Cangzhou Central Hospital, Cangzhou, China; Jie Li: 1.Department of Thyroid and Breast, Cangzhou Central Hospital, Cangzhou, China; Qingqing Wang: 1.Department of Gastroenterology, Cangzhou Central Hospital, Cangzhou, China; Yanting Ji: 1.Department of Thyroid and Breast (Nursing), Cangzhou Central Hospital, Cangzhou, China; Lingbo Xue: 1.Department of Thyroid and Breast (Nursing), Cangzhou Central Hospital, Cangzhou, China; Xuan Zhang: 1.Department of Administrative Center, Cangzhou Central Hospital, Cangzhou, China;

    期刊:TEAD4 overexpression suppresses thyroid cancer progression and metastasis in vitro by modulating Wnt signaling

    DOI:10.1007/s12038-021-00238-3

    影响因子 :2.9

    引用产品: TPC-1 细胞 ,  FTC-133 细胞

  • IGF2BP2 knockdown suppresses thyroid cancer progression by reducing the expression of long non-coding RNA HAGLR (2007-01-20)

    作者:Liangpeng Dong:1.Department of Thyroid Surgery, The first Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China; The first Affiliated Hospital of Xinxiang Medical University, Xinxiang 453100, Henan, China. ; Zushi Geng:1.Department of Thyroid Surgery, The first Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China. ; Zheng Liu:1.Department of Thyroid Surgery, The first Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China. ; Mei Tao:1.Department of Thyroid Surgery, The first Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China. ; Mengjiao Pan:1.Department of Thyroid Surgery, The first Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China. ; Xiubo Lu:1.Department of Thyroid Surgery, The first Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China. Electronic address: doctorluxiubo@126.com. ;

    期刊:IGF2BP2 knockdown suppresses thyroid cancer progression by reducing the expression of long non-coding RNA HAGLR

    DOI:10.1016/j.prp.2021.153550

    影响因子 :2.8

    引用产品: TPC-1 细胞

  • The Antitumour Effect of Prunella vulgaris Extract on Thyroid Cancer Cells In Vitro and In Vivo (2001-01-20)

    作者:Fangqin Yu:1.Department of Thyroid Surgery, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China. ; 2.Key Discipline Laboratory of Clinical Medicine Henan, Zhengzhou, China. ; Lele Zhang:1.Department of Thyroid Surgery, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China. ; 2.Key Discipline Laboratory of Clinical Medicine Henan, Zhengzhou, China. ; Runsheng Ma:1.Department of Thyroid Surgery, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China. ; 2.Key Discipline Laboratory of Clinical Medicine Henan, Zhengzhou, China. ; Chenguang Liu:1.Department of Thyroid Surgery, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China. ; 2.Key Discipline Laboratory of Clinical Medicine Henan, Zhengzhou, China. ; Qingduan Wang:1.Zhengzhou University, Academy of Medical and Pharmaceutical Sciences, Henan Key Laboratory for Pharmacology of Liver Diseases, Zhengzhou, China. ; Detao Yin:1.Department of Thyroid Surgery, The First Aff

    期刊:The Antitumour Effect of Prunella vulgaris Extract on Thyroid Cancer Cells In Vitro and In Vivo

    DOI:10.1155/2021/8869323

    影响因子 :2.7

    引用产品: TPC-1 细胞 ,  B-CPAP [BC-PAP; BCPAP] 细胞 ,  SW579 [SW 579; SW-579] 细胞 ,  FTC-133 细胞

  • Hsa_circRNA_102002 facilitates metastasis of papillary thyroid cancer through regulating miR-488-3p/HAS2 axis (2008-00-20)

    作者:Wei Zhang:1.Department of Endocrinology, Shengjing Hospital of China Medical University, 110000, Shenyang City, Liaoning Province, China. ; Ting Liu:1.Department of Otolaryngology Head and Neck Surgery, Shengjing Hospital of China Medical University, 110000, Shenyang City, Liaoning Province, China. ; Tianshu Li:1.Department of Otolaryngology Head and Neck Surgery, Shengjing Hospital of China Medical University, 110000, Shenyang City, Liaoning Province, China. ; Xudong Zhao:1.Department of Otolaryngology Head and Neck Surgery, Shengjing Hospital of China Medical University, 110000, Shenyang City, Liaoning Province, China. XudongZhaofjk@163.com. ;

    期刊:Hsa_circRNA_102002 facilitates metastasis of papillary thyroid cancer through regulating miR-488-3p/HAS2 axis

    DOI:10.1038/s41417-020-00218-z

    影响因子 :6.4

    引用产品: TPC-1 细胞

  • Glypican 2 regulates cell proliferation and metastasis in thyroid cancer cells (2003-00-20)

    作者:Tao Zhang: 1.Department of Endocrinology and Metabolism, Lanzhou University Second Hospital, 82 Cuiyingmen Lanzhou, Lanzhou, 730030, Gansu, China; Xuan Ren: 1.Department of Endocrinology and Metabolism, Lanzhou University Second Hospital, 82 Cuiyingmen Lanzhou, Lanzhou, 730030, Gansu, China; Zhuan** Wang: 1.Department of Endocrinology and Metabolism, Lanzhou University Second Hospital, 82 Cuiyingmen Lanzhou, Lanzhou, 730030, Gansu, China; Yahong Liu: 1.Department of Pediatrics,Lanzhou University Second Hospital, 82 Cuiyingmen Lanzhou, Lanzhou, 730030, Gansu, China; Hongjuan Wang: 1.Department of Respiratory, Gansu Provincial People’s Hospital, 204 Donggang West Road, Lanzhou, 730000, Gansu, China;

    期刊:Glypican 2 regulates cell proliferation and metastasis in thyroid cancer cells

    DOI:10.1007/s13273-020-00073-x

    影响因子 :1.7

    引用产品: 人甲状腺滤泡上皮细胞 ,  TPC-1 细胞 ,  FTC-133 细胞 ,  B-CPAP [BC-PAP; BCPAP] 细胞 ,  NCI-H1563 细胞 ,  人甲状腺癌组织源细胞

  • 点击展开收起列表
FAQs

Q:{{item.question}}

A:

暂无数据
产品资料
注:百度浏览器无法支持扫一扫功能,请输入识别码,获取相应产品资料

识别码示意图

确定
邱国娜/胡文君

邱国娜/胡文君

【 上海 】

何帆

何帆

【 陕西、甘肃、宁夏、青海、新疆 】

 熊经理

熊经理

【 海南 】

朱莎莉

朱莎莉

【 湖北 】

刘本佳

刘本佳

【江苏(除南京外)】

章臣雄

章臣雄

【 广州 】

杜焱炜

杜焱炜

【 四川、云南、西藏 】

田博浩

田博浩

【 重庆、贵州 】

石文平

石文平

【 北京、辽宁 】

胡文君

胡文君

【江西】

李荣枫

李荣枫

【 天津、河北、内蒙古、山西 】

陈雨兰

陈雨兰

【 山东 】

尹国文

尹国文

【浙江】

唐小花

唐小花

【 吉林、黑龙江 】

付帅

付帅

【 安徽 】

朱俊宇

朱俊宇

【 河南、广西 】

李庆祖

李庆祖

【 湖南 】

熊志亮

熊志亮

【 深圳 】

梅文强

梅文强

【福建】

林钊光

林钊光

【南京】

微信扫一扫咨询

微信扫一扫咨询

在线客服
关闭
在线咨询

关注微信公众号